# Clinical and Translational Core

> **NIH NIH P30** · STANFORD UNIVERSITY · 2020 · $214,768

## Abstract

Project Summary / Abstract: Clinical & Translational Core (CTC)
The goal of the Stanford Clinical & Translational Core (CTC) is to facilitate high-impact diabetes research by
SDRC members. At Stanford, pioneers in cutting-edge technologies of diverse science fields are often in
search of clinical collaborators with human subjects to `translate' their findings to the clinic. Similarly, clinical
investigators often fail to innovate based on a lack of awareness or accessibility to improved or novel
methodologies. In addition, teams of scientists and clinicians attempting to translate their work often encounter
hurdles with regulatory processes, recruitment/retention, sample management, and thoughtful data collection,
leading to inefficient use of time, sample loss, failure to complete studies, and disincentive to provide banked
samples for collaborators. The CTC will address these specific needs by leveraging existing Stanford
resources to focus on diabetes-specific research, thus enhancing our institution's ability to perform innovative
high-impact interdisciplinary studies that surpass the capabilities of a single investigator/laboratory. An online
survey revealed that 76% of SDRC investigators intend to use the CTC.
The CTC will be led by a team of directors that are national leaders in their fields of diabetes-related research:
Drs. Gardner, McLaughlin and Desai. The CTC will develop and provide three core services: 1) A
biorepository of existing and prospectively collected samples with standardization of collection and sample
tracking, and links to clinical data, all accessible via a centralized hub; 2) Advanced support in analytics
including study design, database design with setup of data capture in REDCap and linkage to the electronic
medical record and biorepository, data management, and data analysis, and 3) Clinical trial support that
includes the creation of a Clinical Registry for recruitment, and guidance in the logistics and conduct of trials,
as well as for maximizing retention and compliance. 4) The CTC will orient SDRC investigators and their
teams and train them to use each of these core services effectively.
The CTC will provide access to innovative methodologies and computer-based systems for designing studies,
recording data, logging samples, and linking sample results to phenotypic and metabolic data. The Stanford
CTC will leverage expertise in scientific methods and research-support systems developed on campus but that
are underused or not yet tailored to diabetes research. Institution-wide support exists for collaborative and
“team” science, for modernizing data collection methods, and for resource sharing. Use of the CTC by SDRC
members will advance the planning, execution and communication of coordinated, collaborative, and
transformative clinical and translational research.

## Key facts

- **NIH application ID:** 9980403
- **Project number:** 5P30DK116074-04
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** CHRISTOPHER D GARDNER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $214,768
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9980403

## Citation

> US National Institutes of Health, RePORTER application 9980403, Clinical and Translational Core (5P30DK116074-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9980403. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*